Aerpio Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030

Updated on 02/05/2023

Stock Rating
6
Price Target
$30.81
Consensus
-
Upside
10.35%
Analysts
0
Stock Rating
6
Upside
10.35%
Analysts
0
Price Target
$30.81

Aerpio Pharmaceuticals Stock Forecast and Price Target

If the average 2023 price target of $30.81 recently set by prominent experts for Aerpio Pharmaceuticals is met, there would be a potential upside of approximately 10.35% from the last closing price in September, 2021. The high estimate is $34.51, and the low is $27.42.

$30.81

10.35% Upside

-

Aerpio Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030

Aerpio Pharmaceuticals's Price has seen growth In the last year, going from $0.00 to $0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach $24.48 – an increase of 100.00%. For the next ten years, the forecast is forFair Value to grow by 100.00%.

2021 Fair Value Forecast
$24.48
2022 Fair Value Forecast
$27.60
2023 Fair Value Forecast
$30.73
2024 Fair Value Forecast
$34.17
2025 Fair Value Forecast
$37.99
2026 Fair Value Forecast
$42.24
2027 Fair Value Forecast
$46.97
2028 Fair Value Forecast
$52.22
2029 Fair Value Forecast
$58.07
2030 Fair Value Forecast
$64.57

Aerpio Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030

Aerpio Pharmaceuticals Dividend per Share Forecast for 2023 - 2025 - 2030

Aerpio Pharmaceuticals Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last year, Aerpio Pharmaceuticals's Free Cash Flow has gone down from $-24.09M to $-5.40M – a 77.58% drop. In the next year, analysts are expecting an increase in Free Cash Flow, predicting it will reach $-24.09M – an increase of 346.11%. The Aerpio Pharmaceuticals forecast is for Free Cash Flow to reach $-44.25M or grow by 719.50%.

2021 FCF Forecast
$-24089940.00
2022 FCF Forecast
$-39423186.81
2023 FCF Forecast
$-69600322.21
2024 FCF Forecast
$-32519590.55
2025 FCF Forecast
$-35964499.17
2026 FCF Forecast
$-43288070.02
2027 FCF Forecast
$-55918085.91
2028 FCF Forecast
$-46768023.12
2029 FCF Forecast
$-43657949.59
2030 FCF Forecast
$-44253152.96

Aerpio Pharmaceuticals Net Income Forecast for 2023 - 2025 - 2030

In the last year, Aerpio Pharmaceuticals's Net Income has seen a drop from $-23.27M to $-4.32M – a 81.44% decrease. In the next year, analysts predict that Net Income will reach $-23.27M – an increase of 438.66%. For the next ten years, the forecast is for Net Income to grow by 1198.10%.

2021 NI Forecast
$-23270112.00
2022 NI Forecast
$-44661550.29
2023 NI Forecast
$-90710586.08
2024 NI Forecast
$-36253997.57
2025 NI Forecast
$-42483642.82
2026 NI Forecast
$-54490936.40
2027 NI Forecast
$-75108490.37
2028 NI Forecast
$-59047791.51
2029 NI Forecast
$-54660540.60
2030 NI Forecast
$-56078070.62

Aerpio Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030

In the last year, Aerpio Pharmaceuticals's EBITDA has fallen from $-22.50M to $-6.30M – a 72.00% decrease. For next year, the 0 analysts predict EBITDA of $-22.50M, which would mean an increase of 257.14%. Over the next ten years, the pros' prediction is EBITDAof $-32.07M, which would mean a ten-year growth forecast of 409.12%.

2021 EBITDA Forecast
$-22499820.00
2022 EBITDA Forecast
$-30985252.12
2023 EBITDA Forecast
$-47278330.52
2024 EBITDA Forecast
$-26184315.39
2025 EBITDA Forecast
$-27817343.86
2026 EBITDA Forecast
$-31547649.67
2027 EBITDA Forecast
$-38158985.45
2028 EBITDA Forecast
$-33704559.88
2029 EBITDA Forecast
$-31914847.75
2030 EBITDA Forecast
$-32074421.99

Aerpio Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030

In the last year, Aerpio Pharmaceuticals's EBIT has decreased from $-22.58M to $-6.36M – a 71.83% drop. In the next year, analysts expect EBIT to reach $-22.58M – an increase of 255.03%. For the next ten years, the forecast is for EBIT to grow by 403.20%.

2021 EBIT Forecast
$-22579908.00
2022 EBIT Forecast
$-30962322.51
2023 EBIT Forecast
$-47076147.23
2024 EBIT Forecast
$-26185322.29
2025 EBIT Forecast
$-27798338.15
2026 EBIT Forecast
$-31481617.95
2027 EBIT Forecast
$-38017201.84
2028 EBIT Forecast
$-33621146.06
2029 EBIT Forecast
$-31849311.67
2030 EBIT Forecast
$-32003250.01

Aerpio Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030

Aerpio Pharmaceuticals's EPS has seen growth In the last year, going from $-0.53 to $-1.50 – a gain of 183.02% According to 0 prominent analysts, Aerpio Pharmaceuticals's EPS will fall by 64.67% in the next year, reaching $-0.53. By 2030, professionals believe that Aerpio Pharmaceuticals's EPS will decrease by 10.64%, reaching $-1.34 – a concerning trend for the company.

2021 EPS Forecast
$-0.53
2022 EPS Forecast
$-1.06
2023 EPS Forecast
$-1.30
2024 EPS Forecast
$-1.80
2025 EPS Forecast
$-1.22
2026 EPS Forecast
$-1.23
2027 EPS Forecast
$-1.31
2028 EPS Forecast
$-1.48
2029 EPS Forecast
$-1.39
2030 EPS Forecast
$-1.34